Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Nippon India Nifty Pharma ETF Growth
+26.15%
3Y annualised
+0.41% 1D
NAV: 25 May '26
₹25.31
Min. for SIP
Not Supported
Fund size (AUM)
₹1,356.27 Cr
Expense ratio
0.21%
Rating
--
Holdings (20)
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 22.53% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 9.73% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 9.49% |
| Cipla Ltd. | Healthcare | Equity | 8.67% |
| Lupin Ltd. | Healthcare | Equity | 6.58% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 5.15% |
| Laurus Labs Ltd. | Healthcare | Equity | 5.04% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 4.57% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 4.27% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 3.71% |
| Biocon Ltd. | Healthcare | Equity | 3.02% |
| Mankind Pharma Ltd. | Healthcare | Equity | 2.99% |
| Zydus Lifesciences Ltd. | Healthcare | Equity | 2.63% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 2.50% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 1.97% |
| Gland Pharma Ltd. | Healthcare | Equity | 1.64% |
| Abbott India Ltd. | Healthcare | Equity | 1.55% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 1.40% |
| Wockhardt Ltd. | Healthcare | Equity | 1.36% |
| Piramal Pharma Ltd. | Healthcare | Equity | 1.18% |
See All
Minimum investments
Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported
Returns and rankings
Annualised returns
Absolute returns
| Name | 6M | 1Y | 3Y | All |
|---|---|---|---|---|
| Fund returns | +9.4% | +15.6% | +26.1% | +12.0% |
| Category average (Equity Sectoral) | +0.2% | -2.1% | +22.1% | -- |
| Rank (Equity Sectoral) | -- | 8 | 6 | -- |
Exit load, stamp duty and tax
Exit load
Nil
Stamp duty on investment: 0.005% (from July 1st, 2020)
from July 1st 2020
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Check past data
Fund management
JTJitendra TolaniFeb 2025 - PresentView details
JT
Jitendra Tolani
Feb 2025 - Present
View details
About Nippon India Nifty Pharma ETF Growth
Nippon India Nifty Pharma ETF Growth is a Equity Mutual Fund Scheme launched by Nippon India Mutual Fund. This scheme was made available to investors on 30 Jun 1995. Jitendra Tolani is the Current Fund Manager of Nippon India Nifty Pharma ETF Growth fund. The fund currently has an Asset Under Management(AUM) of ₹7,49,710 Cr and the Latest NAV as of 25 May 2026 is ₹25.31.
The Nippon India Nifty Pharma ETF Growth is rated Very High risk.
;
Investment Objective
The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.
Fund benchmarkNIFTY Pharma Total Return Index
Fund house
Rank (total assets)#4 in India
Total AUM₹7,49,710.38 Cr
Date of Incorporation30 Jun 1995
Launch Date30 Jun 1995
Address30th Floor, One Lodha PlaceSenapati Bapat Marg, Lower ParelMumbai Mumbai 400013
Websitewww.karvymfs.com
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,